COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Weather Update

Baylor’s Emergency Response Team will continue to monitor tropical storm Beta. Baylor and its clinics will be open under normal business operations on Monday. View message. 


Founder and N1 Animal PCR Genotyping


General Description


CRISPR/Cas projects initiated with the core will be genotyped for desired genome editing events in founders using previously designed schemes or schemes approved by the core. For N1 animal genotyping, previously used genotyping designs for screening founders will be used to identify heterozygous animals inheriting the desired targeted allele.

What Will Happen

  1. For N1 PCR genotyping the user Investigator will initiate a project in iLabs. The User will specify the number of animals they have for genotyping. An account number must be provided at this time.
  2. The user will collect tissue from the mice to be genotyped and arrange with the core to drop off the tissue.
  3. The core will have oligonucleotides for PCR synthesized by an approved vendor.
  4. The core will extract DNA from the supplied tissues and resuspend the DNA in nuclease-free water. After genotyping is completed, the user can arrange with the core to have aliquots of the DNA for their own genotyping, if desired.
  5. The core will perform standard PCR on the extracted DNA samples for the designed genotyping reactions.
  6. Within two weeks of dropping off the specified number of samples, the core will provide the user with a genotyping report, including the total number of animals analyzed, total number of animals with genome editing detected, and total number of animals with desired genome editing event. If desired, the user can arrange a consultation meeting to discuss the genotyping results. The core will provide advice as to which founders to breed from founder genotyping.
  7. The user can decide whether they would like to continue with allele QA and have the core perform Sanger sequencing at an additional cost.  

What to Expect

  1. The core will provide genotyping results from the previously designed schemes. If the PCR reactions fail to produce products with appropriate controls, new primers will be designed and PCR repeated.
  2. Indel and point mutations are often too small to detect by conventional PCR. Sanger sequencing and trace analysis will need to be performed to identify and characterize alleles produced.
  3. To verify any allele, Sanger sequencing of PCR products is necessary to verify the sequence at the target site(s).
  4. Founder animals are often mosaic. Thus, detection of desired genome editing events can be difficult at the founder generation. The core can make judgements as to which founders have targeted alleles, but the core cannot be completely certain without sequence confirmation.